Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Gianpietro Dotti
CAR T and AML
Leandro Cerchietti
DLBCL
Nataly Cruz-Rodriguez
T-ALL and metabolism
Peter Klein
MDS
Kura Oncology
MLL leukemia, AML
Stephen Nimer
myeloid cancer biology
Peter Croucher
Multiple Myeloma
Daniel Lucas
bone marrow and leukemia biology
Yubin Zhou
peripheral T cell lymphoma
Kathleen Sakamoto
pediatric AML
Steven Park
follicular lymphoma
Thomas Kipps
Hairy Cell Leukemia
Huda Salman
CMML
Jing Fu
myeloma
Lindsey Montefiori
pediatric leukemia
Hao Jiang
DNA biology and leukemia
Ravi Bhatia
transplantation
Kimberly Stegmaier
childhood blood cancers
Liling Wan
AML
Caner Saygin
T-ALL
Alex Kentsis
pediatric leukemias
Daniel Thomas
Myelofibrosis
Saar Gill
AML immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Neha Mehta-Shah
T-cell lymphoma
Sisi Chen
leukemia
Omar Abdel-Wahab
Hairy cell leukemia
Rizwan Romee
Immunotherapy
Michael Savona
MDS and leukemia
Jennifer Trowbridge
aging and leukemia
Adam Olszewski
Follicular and marginal zone lymphoma
Paolo Strati
Non-Hodgkin Lymphoma
Grant Challen
preleukemia, leukemia
Coleman Lindsley
AML/MDS
Christian Steidl
B-cell lymphomas
Jeffrey Magee
pediatric AML
Tanya Siddiqi
clinical trial access
Adam de Smith
pediatric ALL and Down Syndrome
Marc Seifert
Hairy cell leukemia
Alfred Garfall
myeloma immunotherapy
Nizar Bahlis
Myeloma immunotherapy
Lev Kats
myeloma and epigenetics
Jake Shortt
precision therapy for aggressive lymphomas
Rgenta Therapeutics
RNA-targeting, blood cancer
Richard Lock
T-ALL
James Rubenstein
Lymphoma of the Central Nervous System
Kasey Leger
pediatric blood cancers
Suzanne Lentzsch
Myeloma
Sriram Sundaravel
AML stem cells
Dan Landau
cancer evolution biology
Catherine Smith
leukemia
Caron Jacobson
lymphoma and immunotherapy
Ronald Levy
immunotherapies, COVID-19
Raymond Mailhot
Equity in Access
George Vassiliou
Leukemia Prevention
Jenny Wang
AML
Jayna Mistry
aging and leukemias
Paul Beavis
immunotherapy in myeloma
BioInvent International
immunotherapy, indolent NHL, CTCL
Gaurav Goyal
Erdheim-Chester Disease
Thomas Koehnke
leukemia
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Catriona Jamieson
cancer stem cell biology
Randall Davis
CLL
Carl June
CAR T immunotherapy
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Nirav Shah
CAR-T for lymphoma
Amit Verma
AML/MDS
Mark Hamilton
DLBCL and CAR-T
Riccardo Dalla-Favera
lymphoma (DLBCL)
Justine Kahn
pediatric leukemia and lymphoma
Taishi Yonezawa
AML
Faron Pharmaceuticals
immunotherapy, MDS
Jianguo Tao
Mantle Cell Lymphoma
Oreofe Odejide
Equity in Access
Kerry Rogers
CLL
Yan Liu
MDS
Qing Yi
Novel CAR-T
Daisuke Nakada
preleukemia, leukemia
Megan McNerney
AML/MDS
Tyler Parsons
MPN and AML
H. Irene Su
Equity in Access
Brian Dalton
DNA mutations and myeloid cancers
Matteo Bellone
Smoldering multiple myeloma
Eric Pietras
AML
Reina Takeda
AML
Ricky Johnstone
lymphoma and myeloma
Matthew Frank
Lymphoma CART therapy
Bingyi Chen
AML immunotherapy
Yiman Liu
Epigenetics and leukemia
Julia Paczkowska
immunobiology of Hodgkin's disease
Wendy Stock
T-cell ALL
Jonas Jutzi
myeloproliferative neoplasms
Ari Melnick
epigenetics and lymphoma
Jun Qi
Myeloma
Arash Alizadeh
blood cancer biology and diagnosis
Rong Lu
preleukemia, leukemia
Mark Murakami
follicular lymphoma
John DiPersio
trispecific antibody for AML and MDS
Jaroslaw Maciejewski
bone marrow failure
Siddhartha Jaiswal
preleukemia
Eirini Papapetrou
blood cancer stem cells
Christopher Porter
Leukemia, lymphoma
Jeetayu Biswas
splicing in myeloid diseases
Carma Bylund
Equity in Access
Suman Paul
T cell cancers and immunotherapy
John Leonard
lymphoma research
Britta Will
Leukemia and pre-leukemia
Tycel Phillips
Mantle Cell Lymphoma
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Anouchka Laurent
T-cell lymphoma
Daniel Herranz
T-ALL
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Takeshi Sugio
T-cell lymphoma
Pietro Genovese
transplant and AML
George Daley
"off-the-shelf" CAR-T and CAR-NK
Noemí Puig Morón
Myeloma
F. Lennie Wong
Equity in Access
Cailin Collins
Leukemia and pre-leukemia
Dane Vassiliadis
blood cancer biology
Affimed
immunotherapy, HL, PTCL
Kirk Schultz
pediatric transplantation
Trent Hall
MDS
Margaret Shipp
lymphoma biology
Anthony Letai
improving CAR-T
Christian Marinaccio
MLL leukemias
Daniel Pollyea
AML
Craig Jordan
AML
Michael Wang
Mantle Cell Lymphoma
Shazia Nakhoda
Equity in Access
Lawrence Boise
CART and myeloma
Adi Nagler
Bronchiolitis obliterans after transplant
Constellation Pharmaceuticals
myeloproliferative neoplasms
Shannon Maude
Immunotherapy for ALL
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Rajni Kumari
AML
Catherine Bollard
pediatric blood cancers and immunotherapy
Sahand Hormoz
MPN
Michael Kharas
leukemia
Daniel Starczynowski
MDS and AML
Joachim Yahalom
Lymphoma
Hong Wen
AML
Frederike Kramer
MPNs
Jing Yang
Myeloma
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Jonathon Cohen
lymphoma clinical trial access in Georgia
Solu Therapeutics
immunotherapy, CMML
Sham Mailankody
Myeloma immunotherapy clinical trials
Liran Shlush
pre-leukemia
Paolo Caimi
CAR-T clinical trial for CLL
Roland Walter
Antibody-based AML therapies
Fenghuang Zhan
Myeloma and bone disease
Logan Spector
childhood leukemia epidimiology
Jonathan Licht
DNA biology, myeloma
Maximilian Stahl
AML immunotherapy
Ryvu Therapeutics
AML, MDS, Myelofibrosis
John Crispino
myelofibrosis, pediatric leukemia and Downs
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Caroline Arber
myeloma CAR-T
Amin Sobh
Myeloma biology
Brian Walker
smoldering myeloma, MGUS
Soheil Meshinchi
pediatric AML
Gareth Morgan
smoldering myeloma, MGUS
Qingyu Luo
BPDCN
Manyi Wei
acute megakaryoblastic leukemia
Eric Padron
CMML
Alison Moskowitz
lymphoma therapeutics
Carl Allen
pediatric blood cancers
Ana Vujovic
AML
Sergei Doulatov
Leukemias
Grzegorz Nowakowski
Clinical trial access
Teresa Palomero
Peripheral T-cell Lymphoma
Steven Treon
Lymphomas and Waldenstrom's
Simona Colla
Myeloma biology
Lori Muffly
Equity in Access
Susan Schwab
cancer immunology
Catherine Diefenbach
DLBCL immunology
Jean Koff
Disparities in DLBCL
Ann-Kathrin Eisfeld
Racial diversity in AML
Alexey Danilov
lymphoma
Ravindra Majeti
preleukemia, AML
Timothy Graubert
AML and MDS biology
Xu Ji
Equity in Access
Bing Carter
p53 mutant AML
Ryan Wilcox
T-cell lymphoma
Fahmin Basher
transplant and GvHD
Andrew Lane
BPDCN
Pooja Khandelwal
bone marrow transplantation
Julia Maxson
AML
Bailee Kain
AML and African ancestry
Helen Parsons
Equity in Access
Lucy Godley
preleukemia
Roberta Zappasodi
lymphoma, immunotherapy
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Jalpa Doshi
Equity in Access
Sigurður Kristinsson
Smoldering myeloma
Tomasz Skorski
myeloproliferative neoplasms, AML
Rachel Mersfelder
AMKL
Michael Keller
COVID-19, immunotherapy
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Robert Soiffer
transplantation
Christine Zhang
AML
Koichi Takahashi
AML/MDS
Mark Dawson
B-ALL and CAR-T resistance
Ruben Carrasco
Myeloma
Courtney DiNardo
clinical trials, AML
Christopher Flowers
clinical trial access
Armin Rashidi
gut bacteria and transplant success
Nicoletta Cieri
AML and transplantation
Sarah Tasian
pediatric leukemias
Jaehyuk Choi
T-cell lymphoma
Marco Ruella
Immunotherapy for T-cell lymphoma
Nicola Vannini
Aging and CAR-T success
Venkata Lokesh Battula
immunotherapy and AML
Areej El-Jawahri
transplant survivorship
Bruno Paiva
smoldering myeloma
Michael Green
lymphoma biology
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Anushree Vichare
Equity in Access
Eugenio Morelli
Myeloma
Jessica Stewart
Epstein-barr virus and lymphomas
Jianhua Yu
myeloma immunotherapy
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Stephen Gottschalk
pediatric leukemia and CAR-T
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Lakshmi Nayak
brain tumors in lymphoma
Inhye Ahn
CLL
Keisuke Ito
blood cancer stem cells and MDS metabolism
Sam Butterworth
CMML
Urvi Shah
Diet and myeloma
Sheng Li
Aging and AML
Elliot Stieglitz
CMML
Mala Shanmugam
myeloma
Thomas LeBlanc
palliative care
Dimericon Therapeutics
dimericons, blood cancer
Luca Busino
DLBCL
Christopher Booth
BPDCN
ImCheck Therapeutics
immunotherapy, AML
Yibin Yang
Lymphoma
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Yoke Seng Lee
AML
Nicolas Nassar
pediatric leukemia
Mendel Goldfinger
MDS/AML trials for the elderly
Philippe Armand
follicular lymphoma
William Matsui
Myeloma
Alec Zhang
myeloma, immunotherapy
Jolanta Grembecka
leukemia therapeutics
Markus Muschen
leukemia and lymphoma biology
Meng Li
Equity in Access
Jennifer Woyach
CLL trials
Tak Mak
Immunotherapy
Enrico Tiacci
Hairy cell leukemia
Frederick Locke
lymphoma and immunotherapy
Siegfried Janz
Myeloma immunotherapy
Robert Orlowski
(Smoldering) Multiple Myeloma
Steven Horwitz
T-cell lymphomas
Piers Patten
COVID-19
Enterome
vaccine, FL, MZL
Courtney Jones
AML metabolism
Nitin Jain
CLL
Srividya Swaminathan
pediatric, immunotherapy
Michaela Reagan
Multiple Myeloma
Alieen Rowan
Adult T cell leukemia/lymphoma
Jeremy Baeten
AML
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Stephen Oh
myeloproliferative neoplasms
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Stacie Dusetzina
Equity in Access
Wendy Béguelin
follicular lymphoma
Martin Dreyling
Mantle Cell Lymphoma
Marina Konopleva
MDS/AML metabolism